klisemfg Chapter 245 Talking about cooperation isn't scary, but women...
Chapter 245 Talking about cooperation isn't scary, but women...
……
"It seems the negotiations aren't going well!?"
Gao Tianlong had just left when Luo Shiyun came to Chen Xuan's office wearing high heels.
"AbbVie offered 20 billion to acquire the new drug formula."
"They even plan to spend an additional 120 billion to acquire 60% of our group's shares."
After taking a sip of tea, Chen Xuan told Gao Tianlong about his offer.
The failure of the cooperation did not cause him any emotional fluctuations.
Because from the beginning, he had no intention of selling the formula.
The main reason is that it is difficult for pharmaceutical companies to accept our prices.
"Then what? How did you reject her?" Luo Shiyun walked behind Chen Xuan, put her hands on his shoulders and massaged them gently.
Chen Xuan's expression, which had been calm just now, twitched instantly and even became extremely unnatural.
But for some reason, he didn't resist too much this time.
"I didn't refuse either."
"It just raised the price from 200 billion to 1000 billion."
"Obviously, they thought the new drug formula was worth more than 1000 billion yuan, so they left." After taking another sip of tea, Chen Xuan pretended to be calm.
He was very calm about the negotiation just now.
But when he saw Luo Shiyun's hand on his shoulder, he became very upset.
At the same time, Luo Shiyun was also shocked.
Chen Xuan’s price is too scary.
Even the wealthy AbbVie would probably be shocked, as this is 1000 billion yuan.
Moreover, Chen Xuan acted as if it was a matter of course, as if 1000 billion was already the lowest offer and there was no way it could go any lower.
This attitude surprised her the most, because she knew that Chen Xuan was serious and not just asking for an exorbitant price.
When she thought of the expressions of Gao Tianlong and the others, Luo Shiyun inexplicably felt a little funny and suddenly understood their feelings.
However, although she was shocked, after careful consideration, she felt that 1000 billion was not too outrageous.
As long as the specific drug for lung cancer can be successfully launched on the market, then the profit of 1000 billion yuan will not be a problem and there is every chance that it can be achieved.
However, this is only the first phase of clinical trials, and the risks are still very high, so pharmaceutical companies dare not gamble on this probability.
If it has passed clinical trials, then it is estimated that AbbVie will most likely agree to the 1000 billion yuan offer, but now it is only the first phase.
"That's good too. No one will bother me anymore in the future."
"If they can't accept a 1000 billion yuan acquisition price, there's no need for them to come to me for negotiations."
Chen Xuan didn't care at all. He felt that independently developing a specific drug for lung cancer would only bring him greater profits.
Of course, if these pharmaceutical companies insist on acquiring it, then he can sell it and just treat it as a one-time payment for a few years of profit.
But if they are not willing to give even 1000 billion, then he naturally won't consider it.
"Do you want me to spread this news?"
"Let the outside world know about AbbVie's offer, and then they won't bother you anymore."
Luo Shiyun thought for a moment and said.
Doing so can increase the popularity of the lung cancer drug and let the outside world see the strength of this drug.
Secondly, it can allow some pharmaceutical companies to see AbbVie’s bid, thus preventing them from acquiring the company at a lower price.
Even if they still want to acquire this drug formula in the future, their bid will at least not be lower than AbbVie.
"Okay, let's do as you say." Chen Xuan nodded and agreed to the idea.
Doing so will not affect him anyway, and will help him resist most pharmaceutical companies in advance, so why not do it?
"Wow, this negotiation only took 15 minutes."
"It won't delay my experiment today."
After that, Chen Xuan glanced at the wall clock again and muttered with a smile.
From the beginning to the end of his negotiations with the AbbVie delegation, the entire process took only a quarter of an hour, which was very quick.
Hearing this, Luo Shiyun couldn't help but smile.
The AbbVie delegation prepared for so long, but in the end they only managed to get a quarter of an hour.
If it were any other company, they would never treat the AbbVie delegation like this. Only Chen Xuan could do this.
The key is that he is qualified to do so, and even giants like AbbVie are obedient and have no way to disobey his rules.
……
When the AbbVie delegation came out,
The reporters who had been squatting outside for a long time immediately took action.
"Mr. Gao, are you discussing cooperation with Antai Pharmaceutical Group on a lung cancer drug today?"
"I heard that AbbVie is planning to acquire Chen Xuan's new drug patent. Is this true?"
"Mr. Gao, how much does AbbVie plan to pay for the patent? And has Mr. Chen agreed to cooperate with you?"
"Mr. Gao, did your negotiations go smoothly this time? Will the two groups become partners in the future?"
"Mr. Gao, in addition to acquiring the new drug patents, will AbbVie also consider acquiring Antai Pharmaceutical Group?"
Various problems are basically related to new drug patents.
Everyone knows that the reason why the AbbVie delegation came to negotiate in person was for the patent of the lung cancer drug.
This is also what attracts the public's attention the most, and everyone comes here for this matter.
Especially since Changfeng Group came last time and was rejected by Chen Xuan without hesitation, the heat of this matter has become extremely high.
Now, the international giant AbbVie has also taken action personally, which makes them even more interested.
Will the wealthy AbbVie have a different outcome from Changfeng Group?
"I'm sorry, this is a commercial secret. I can't comment."
"But we at AbbVie are indeed planning to cooperate with Aetna Pharmaceuticals."
"As for the specific content of the cooperation, it is not convenient to disclose it to the public for the time being. Please forgive me."
Faced with many questions from reporters, Gao Tianlong's answers were also very simple.
Of course, he hadn't reached a cooperation in the first place, so there was no way it couldn't be simple.
However, Chen Xuan rejected Abovie's offer outright, and this must not be made public.
Not only will it let other competitors know AbbVie's trump card, but it will also have a negative impact on AbbVie, causing stock price fluctuations.
Therefore, he could only say that he had no comment and simply revealed that both parties had the intention to cooperate.
This sentence is ambiguous and is not an answer at all.
Having the intention to cooperate but ultimately not cooperating also fits the meaning of this sentence.
Most importantly, it can also send a signal to the outside world, making it think that Abovie and Antai Pharmaceutical Group have really started cooperation.
This signal is good news for AbbVie, and will also successfully mislead competitors and cause them to misjudge.
After saying what needs to be said,
Gao Tianlong did not reveal any other information and just got into the car and left.
This left all the reporters and onlookers dumbfounded.
Is this cooperation or not?
Did AbbVie acquire Chen Xuan’s formula?
"What's the point? You're only talking halfway?"
"Are there any intentions to cooperate? Does that mean that AbbVie has already made an offer, Chen Xuan has agreed, and both parties are waiting to sign the contract?"
"No way! Is AbbVie really going to acquire the new drug formula? Will this kind of black-hearted capital take away this miracle drug for lung cancer?"
"It's not just the formula for the lung cancer drug, it's very likely that the entire Antai Pharmaceutical Group was sold to AbbVie."
"What? What nonsense are you talking about? How could Chen Xuan possibly sell Antai Pharmaceutical Group? Is he going to work for AbbVie? What price would AbbVie have to pay for him to agree to such terms?"
"AbbVie is incredibly wealthy. Its revenue last year was $500 billion. Do you think it can't afford this price?"
"Is Chen Xuan really that short-sighted? Would he really sell himself to AbbVie? No! This news is terrible."
……